164 related articles for article (PubMed ID: 22087608)
1. Haemodynamic, endocrine and renal actions of adrenomedullin 5 in an ovine model of heart failure.
Rademaker MT; Charles CJ; Nicholls MG; Richards AM
Clin Sci (Lond); 2012 May; 122(9):429-37. PubMed ID: 22087608
[TBL] [Abstract][Full Text] [Related]
2. Long-term adrenomedullin administration in experimental heart failure.
Rademaker MT; Charles CJ; Espiner EA; Nicholls MG; Richards AM
Hypertension; 2002 Nov; 40(5):667-72. PubMed ID: 12411460
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic, hormonal, and renal actions of adrenomedullin 2 in experimental heart failure.
Rademaker MT; Charles CJ; Nicholls MG; Richards AM
Circ Heart Fail; 2008 Jul; 1(2):134-42. PubMed ID: 19808282
[TBL] [Abstract][Full Text] [Related]
4. Combined endopeptidase inhibition and adrenomedullin in sheep with experimental heart failure.
Rademaker MT; Charles CJ; Cooper GJ; Coy DH; Espiner EA; Lewis LK; Nicholls MG; Richards AM
Hypertension; 2002 Jan; 39(1):93-8. PubMed ID: 11799085
[TBL] [Abstract][Full Text] [Related]
5. Beneficial hemodynamic and renal effects of adrenomedullin in an ovine model of heart failure.
Rademaker MT; Charles CJ; Lewis LK; Yandle TG; Cooper GJ; Coy DH; Richards AM; Nicholls MG
Circulation; 1997 Sep; 96(6):1983-90. PubMed ID: 9323090
[TBL] [Abstract][Full Text] [Related]
6. Natriuretic peptide analogues with distinct vasodilatory or renal activity: integrated effects in health and experimental heart failure.
Rademaker MT; Scott NJA; Koh CY; Kini RM; Richards AM
Cardiovasc Res; 2021 Jan; 117(2):508-519. PubMed ID: 32167565
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic, hormonal, and renal actions of adrenomedullin-2 in normal conscious sheep.
Charles CJ; Rademaker MT; Richards AM
Endocrinology; 2006 Apr; 147(4):1871-7. PubMed ID: 16410298
[TBL] [Abstract][Full Text] [Related]
8. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
Rademaker MT; Charles CJ; Nicholls MG; Richards AM
Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic, hormone, and urinary effects of adrenomedullin infusion in essential hypertension.
Troughton RW; Lewis LK; Yandle TG; Richards AM; Nicholls MG
Hypertension; 2000 Oct; 36(4):588-93. PubMed ID: 11040240
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic, hormonal, and renal effects of (pro)renin receptor blockade in experimental heart failure.
Rademaker MT; Yandle TG; Ellmers LJ; Charles CJ; Nicholls MG; Richards AM
Circ Heart Fail; 2012 Sep; 5(5):645-52. PubMed ID: 22798523
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic, Hormonal, and Renal Actions of Phosphodiesterase-9 Inhibition in Experimental Heart Failure.
Scott NJA; Rademaker MT; Charles CJ; Espiner EA; Richards AM
J Am Coll Cardiol; 2019 Aug; 74(7):889-901. PubMed ID: 31416533
[TBL] [Abstract][Full Text] [Related]
12. Adrenomedullin modulates the neurohumoral response to acute volume loading in normal conscious sheep.
Charles CJ; Nicholls MG; Rademaker MT; Richards AM
J Endocrinol; 2002 Apr; 173(1):123-9. PubMed ID: 11927391
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic, hormonal, and renal actions of adrenomedullin-5 in normal conscious sheep.
Charles CJ; Rademaker MT; Richards AM
J Cardiovasc Pharmacol; 2011 Jul; 58(1):25-31. PubMed ID: 21436721
[TBL] [Abstract][Full Text] [Related]
14. Beneficial hemodynamic, endocrine, and renal effects of urocortin in experimental heart failure: comparison with normal sheep.
Rademaker MT; Charles CJ; Espiner EA; Fisher S; Frampton CM; Kirkpatrick CM; Lainchbury JG; Nicholls MG; Richards AM; Vale WW
J Am Coll Cardiol; 2002 Oct; 40(8):1495-505. PubMed ID: 12392842
[TBL] [Abstract][Full Text] [Related]
15. Combined angiotensin-converting enzyme inhibition and adrenomedullin in an ovine model of heart failure.
Rademaker MT; Charles CJ; Cooper GJ; Coy DH; Espiner EA; Lewis LK; Nicholls MG; Richards AM
Clin Sci (Lond); 2002 Jun; 102(6):653-60. PubMed ID: 12049620
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
[TBL] [Abstract][Full Text] [Related]
17. Prolonged urocortin 2 administration in experimental heart failure: sustained hemodynamic, endocrine, and renal effects.
Rademaker MT; Charles CJ; Ellmers LJ; Lewis LK; Nicholls MG; Richards AM
Hypertension; 2011 Jun; 57(6):1136-44. PubMed ID: 21536988
[TBL] [Abstract][Full Text] [Related]
18. Integrated hemodynamic, hormonal, and renal actions of urocortin 2 in normal and paced sheep: beneficial effects in heart failure.
Rademaker MT; Cameron VA; Charles CJ; Richards AM
Circulation; 2005 Dec; 112(23):3624-32. PubMed ID: 16330704
[TBL] [Abstract][Full Text] [Related]
19. Beneficial renal and hemodynamic effects of omapatrilat in mild and severe heart failure.
Troughton RW; Rademaker MT; Powell JD; Yandle TG; Espiner EA; Frampton CM; Nicholls MG; Richards AM
Hypertension; 2000 Oct; 36(4):523-30. PubMed ID: 11040230
[TBL] [Abstract][Full Text] [Related]
20. Central and peripheral cardiovascular actions of adrenomedullin 5, a novel member of the calcitonin gene-related peptide family, in mammals.
Takei Y; Hashimoto H; Inoue K; Osaki T; Yoshizawa-Kumagaye K; Tsunemi M; Watanabe TX; Ogoshi M; Minamino N; Ueta Y
J Endocrinol; 2008 May; 197(2):391-400. PubMed ID: 18434369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
